Gerry Proehl is the founder of Dermata Therapeutics. Dermata Therapeutics has raised $9M in total funding. Latest round: Growth.
Gerry Proehl is the Chairman, President, and Chief Executive Officer of Dermata Therapeutics, a late-stage biotechnology company focused on treating medical skin diseases and aesthetic applications. The company recently reported positive topline results from its XYNGARI™ Phase 3 STAR-1 clinical trial for acne treatment and raised $8.8 million in gross proceeds from private placement and warrant inducement financings during the first quarter of 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library